Drug recall D-0347-2024
Product
CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic or Intravaginal Use, Rx Only, Net Wt. 50g, Distributed by Bausch Health US, LLC Bridgewater, NJ 08807 USA, Manufactured by: Bausch Health Companies, Inc. Laval Quebec H7L 448, Canada, NDC 0187-0006-25.
Reason for recall
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
Lots and codes
Lot: 7001796, Exp 05/31/2025
Recall details
- Recalling firm
- MCKESSON CORPORATION, IRVING, TX
- Quantity
- 42 units
- Distribution
- Nationwide in the US
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 12, 2024
- Terminated
- October 1, 2024
Related products
- Cabtreo – drug information
- NDC 0187-0006 Cabtreo · Clindamycin Phosphate 12 mg/g; Benzoyl Peroxide 31 mg/g;… · Bausch Health US LLC